Average Sales Price Final Rule Includes PhRMA's Estimation Method
This article was originally published in The Pink Sheet Daily
Executive Summary
Calculations of ASP for Medicare Part B drugs will be based on a rolling average percentage of price concessions divided by total sales, as proposed in manufacturers' comments. The final rule will be published Sept. 16.
You may also be interested in...
Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005
The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says
Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005
The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says
Average Sales Price Formula Could Produce Negative ASP, PhRMA Says
PhRMA recommends an alternative methodology that would "smooth out extreme fluctuations in ASP." The trade association proposes calculating the average ratio between rebates and sales revenue.